Furthermore, it was recently found that Faecalibacterium could ameliorate renal dysfunction in patients with chronic kidney disease partly through the butyrate-mediated GPR43 signaling in the kidney [24]. This evidence concerns the gene FFAR2 and chronic kidney disease.